Solving data to enable precision diagnostics for all.
Concr is an emerging software platform to combat cancer. It combines cutting edge machine learning techniques with a deep scientific understanding of tumour progression to accurately predict cancer evolution in response to treatment.This will enable clinicians to adapt treatments proactively, rather than reactively, to prevent treatment resistance and improve treatment efficacy through precision medicine.Concr aims to:• Reduce treatment resistance• Cut the cost of cancer treatment• Enable proactive treatment adaptation• Save lives
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 1, 2021 | Seed | £499.84K | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Accelerate@Babraham | — | Seed |
KQ Labs | — | Seed |